TG THERAPEUTICS, INC. Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31)
TG THERAPEUTICS, INC. (TGTX) reported Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfSecuritiesNet · last filed 2017-11-09
- 2017-09-30: Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 9 month $0.00.
- 2016-09-30: Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 9 month -$33.04K.
- 2015-09-30: Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 9 month $0.00.
| Period end | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 9 month |
|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2016-09-30 | -$33.04K 10-Q · filed 2017-11-09 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |